Literature DB >> 33388912

Girls and renal scarring as risk factors for febrile urinary tract infection after stopping antibiotic prophylaxis in children with vesicoureteral reflux.

Michiko Nakamura1, Kimihiko Moriya2,3, Masafumi Kon1, Yoko Nishimura1, Hiroki Chiba1, Takeya Kitta1, Nobuo Shinohara1.   

Abstract

PURPOSE: To clarify the incidence of and risk factors for febrile urinary tract infection in children with persistent vesicoureteral reflux (VUR) after the discontinuation of continuous antibiotic prophylaxis (CAP), retrospective chart review was performed. PATIENTS AND METHODS: Among children with primary VUR at 10 years of age or younger at presentation, those who had persistent VUR despite conservative management with CAP and who were subsequently followed after discontinuation of CAP were included. Kaplan-Meier curve and Cox's proportional hazard regression model were used for evaluation of the incidence of and risk factors for febrile urinary tract infection (fUTI) after stopping CAP.
RESULTS: Among 144 children (99 boys and 45 girls), fUTI developed in 34. The 5-year fUTI-free rate after discontinuation of CAP was 69.4%. On multivariate analyses, girls (p = 0.008) and abnormalities on nuclear renal scans (p = 0.0019), especially focal defect (p = 0.0471), were significant factors for fUTI. Although the fUTI-free rate was not different between children who had no or 1 risk factor, it was significantly lower in children with 2 risk factors than in those with no or 1 risk factor.
CONCLUSIONS: The present study revealed that girls and abnormal renal scan, especially focal defect, are risk factors for fUTI. Active surveillance without CAP for persistent VUR seems to be a safe option for children with no or 1 risk factor. Prophylactic surgery or careful conservative follow-up may be an option for girls with abnormal renal scan results if VUR persists under CAP.
© 2021. Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Continuous antibiotic prophylaxis; Febrile urinary tract infection; Risk factor; Vesicoureteral reflux

Mesh:

Year:  2021        PMID: 33388912     DOI: 10.1007/s00345-020-03524-1

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  18 in total

1.  Nomograms for predicting annual resolution rate of primary vesicoureteral reflux: results from 2,462 children.

Authors:  Carlos R Estrada; Carlo C Passerotti; Dionne A Graham; Craig A Peters; Stuart B Bauer; David A Diamond; Bartley G Cilento; Joseph G Borer; Marc Cendron; Caleb P Nelson; Richard S Lee; Jing Zhou; Alan B Retik; Hiep T Nguyen
Journal:  J Urol       Date:  2009-08-15       Impact factor: 7.450

2.  Antibiotic prophylaxis for prevention of febrile urinary tract infections in children with vesicoureteral reflux: a meta-analysis of randomized, controlled trials comparing dilated to nondilated vesicoureteral reflux.

Authors:  Jose de Bessa; Flavia Cristina de Carvalho Mrad; Evilin Feitosa Mendes; Marcia Carvalho Bessa; Victor Pereira Paschoalin; Ricardo Brianezi Tiraboschi; Zein Mohamed Sammour; Cristiano Mendes Gomes; Luis H Braga; José Murillo Bastos Netto
Journal:  J Urol       Date:  2015-03-25       Impact factor: 7.450

3.  Early discontinuation of antibiotic prophylaxis in patients with persistent primary vesicoureteral reflux initially detected during infancy: outcome analysis and risk factors for febrile urinary tract infection.

Authors:  Kimihiko Moriya; Takahiko Mitsui; Takeya Kitta; Michiko Nakamura; Yukiko Kanno; Masafumi Kon; Yoko Nishimura; Nobuo Shinohara; Katsuya Nonomura
Journal:  J Urol       Date:  2014-08-09       Impact factor: 7.450

4.  The Swedish reflux trial: review of a randomized, controlled trial in children with dilating vesicoureteral reflux.

Authors:  Per Brandström; Ulf Jodal; Ulla Sillén; Sverker Hansson
Journal:  J Pediatr Urol       Date:  2011-07-31       Impact factor: 1.830

5.  Antimicrobial prophylaxis for children with vesicoureteral reflux.

Authors:  Alejandro Hoberman; Saul P Greenfield; Tej K Mattoo; Ron Keren; Ranjiv Mathews; Hans G Pohl; Bradley P Kropp; Steven J Skoog; Caleb P Nelson; Marva Moxey-Mims; Russell W Chesney; Myra A Carpenter
Journal:  N Engl J Med       Date:  2014-05-04       Impact factor: 91.245

Review 6.  Summary of the AUA Guideline on Management of Primary Vesicoureteral Reflux in Children.

Authors:  Craig A Peters; Steven J Skoog; Billy S Arant; Hillary L Copp; Jack S Elder; R Guy Hudson; Antoine E Khoury; Armando J Lorenzo; Hans G Pohl; Ellen Shapiro; Warren T Snodgrass; Mireya Diaz
Journal:  J Urol       Date:  2010-07-21       Impact factor: 7.450

7.  Abnormal dimercapto-succinic acid scan is a predictive factor of breakthrough urinary tract infection in children with primary vesicoureteral reflux.

Authors:  Michiko Nakamura; Kimihiko Moriya; Takahiko Mitsui; Hiroshi Tanaka; Katsuya Nonomura
Journal:  J Urol       Date:  2009-08-18       Impact factor: 7.450

8.  Spontaneous resolution of vesicoureteral reflux: a 15-year perspective.

Authors:  C William Schwab; Hsi-Yang Wu; Heather Selman; Grahame H H Smith; Howard M Snyder; Douglas A Canning
Journal:  J Urol       Date:  2002-12       Impact factor: 7.450

9.  Predictive factors of early spontaneous resolution in children with primary vesicoureteral reflux.

Authors:  Matthew J Knudson; J Christopher Austin; Zeb M McMillan; Charles E Hawtrey; Christopher S Cooper
Journal:  J Urol       Date:  2007-08-17       Impact factor: 7.450

Review 10.  Vesicoureteral reflux and continuous prophylactic antibiotics.

Authors:  Ted Lee; John M Park
Journal:  Investig Clin Urol       Date:  2017-05-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.